Therapeutic Asset Ratings
416 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FULVESTRANT
Neoplasm Metastasis
Eli Lilly and Company
P4
BB
(66)
INSULIN GLARGINE (SANOFI)
Diabetes Mellitus, Type 2
Eli Lilly and Company
P4
BB
(66)
Carboplatin
Endometrial Neoplasms
Eli Lilly and Company
P3
BB
(66)
CIS-DIAMMINEDICHLOROPLATINUM II
Endometrial Neoplasms
Eli Lilly and Company
P3
BB
(66)
Orforglipron
Overweight
Eli Lilly and Company
P3
BB
(66)
Retatrutide
CKD
Eli Lilly and Company
P3
BB
(66)
Retatrutide
Overweight
Eli Lilly and Company
P3
BB
(66)
Epirubicin
Urinary Bladder Neoplasms
Eli Lilly and Company
P2
BB
(66)
Pembrolizumab
Urinary Bladder Neoplasms
Eli Lilly and Company
P2
BB
(66)
Letrozole
Neoplasm Metastasis
Eli Lilly and Company
P4
BB
(65)
Abemaciclib
Breast Neoplasms
Eli Lilly and Company
P4
BB
(64)
Zoladex
Breast Neoplasms
Eli Lilly and Company
P4
BB
(64)
CIS-DIAMMINEDICHLOROPLATINUM II
Neoplasm Metastasis
Eli Lilly and Company
P3
BB
(64)
Cyclophosphamide
Uterine Cervical Neoplasms
Eli Lilly and Company
P3
BB
(64)
Donanemab
Central Nervous System Diseases
Eli Lilly and Company
P3
BB
(64)
Epirubicin
Uterine Cervical Neoplasms
Eli Lilly and Company
P3
BB
(64)
Hycamtin
Metastases
Eli Lilly and Company
P3
BB
(64)
Hycamtin
Peritoneal Neoplasms
Eli Lilly and Company
P3
BB
(64)
Inno-206
Neoplasm Metastasis
Eli Lilly and Company
P3
BB
(64)
Palbociclib
Metastasis
Eli Lilly and Company
P3
BB
(64)
PREDNISONE TABLETS
Urogenital Neoplasms
Eli Lilly and Company
P3
BB
(64)
Retatrutide
Obstructive Sleep Apnea
Eli Lilly and Company
P3
BB
(64)
Retatrutide
Osteo Arthritis Knee
Eli Lilly and Company
P3
BB
(64)
Solanezumab
Alzheimer's Disease
Eli Lilly and Company
P3
BB
(64)
Tirzepatide
Obstructive Sleep Apnea
Eli Lilly and Company
P3
BB
(64)
Showing 26 to 50 of 416 assets
Previous
Page 2 of 17
Next